Implementing Photobiomodulation for Dry AMD
Dry age-related macular degeneration progresses in quiet increments that add up to meaningful loss.
Clinics see this trajectory every week, yet most interventions have focused on watchful waiting rather than proactive support.
Photobiomodulation offers a noninvasive option that targets retinal bioenergetics and microvascular dynamics.
Why scale matters when the disease is slow but relentless
Interest has moved beyond single-site pilots into system-wide adoption, with the question now being how to implement dosing, measurement, and safety at scale.
Author's summary: Scaling photobiomodulation for Dry AMD treatment.